WHO’s New Pricing Policy Guideline Makes Medicines More Affordable

October 12, 2020

A new WHO guideline aims to help governments overcome the barrier of high prices for pharma products, enabling them to better address public health needs. Over 50 international experts from a diverse array of stakeholder groups evaluated and assessed scientific evidence and country experiences to prepare the guideline covering THE FOLLOWING 10 policy pricing approaches:

  1. External reference pricing
  2. Internal reference pricing
  3. Value-based pricing
  4. Regulation of mark-ups across the pharmaceutical supply and distribution chain
  5. Promoting price transparency
  6. Tendering and negotiation
  7. Promoting the use of quality assured generic and biosimilar medicines
  8. Pooled procurement
  9. Cost-plus pricing
  10. Tax exemptions or tax reductions

Read more here.

Share This Story!